Year archive

Ocumension Therapeutics — 2022 filings

All 49 regulatory filings released by Ocumension Therapeutics (1477) in 2022, sourced directly from the official regulator.

49 Filings

2022 Period

2022 filings (49)

Filing	Released	Lang
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 November 2022 Share Issue/Capital Change	2022-12-06	English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON NOVEMBER 25, 2022 Declaration of Voting Results & Voting Rights Announcements	2022-11-25	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 October 2022 Regulatory Filings	2022-11-04	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS Report Publication Announcement	2022-11-04	English
NOTIFICATION LETTER AND REQUEST FORM TO REGISTERED SHAREHOLDERS Report Publication Announcement	2022-11-04	English
Documents on Display Regulatory Filings	2022-11-04	English
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, NOVEMBER 25, 2022 Proxy Solicitation & Information Statement	2022-11-04	English
NOTICE OF EXTRAORDINARY GENERAL MEETING AGM Information	2022-11-04	English
(1) REFRESHMENT OF THE SCHEME MANDATE LIMIT AND SET OF THE SERVICE PROVIDER SUBLIMIT; (2) GRANT TO EMPLOYEE PARTICIPANTS AND CONNECTED TRANSACTION INVOLVING THE PROPOSED CONNECTED GRANT; AND Proxy Solicitation & Information Statement	2022-11-04	English
DELAY IN DESPATCH OF CIRCULAR IN RELATION TO PROPOSED CONNECTED GRANT TO DIRECTORS UNDER THE 2021 SHARE AWARD SCHEME Regulatory Filings	2022-10-14	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 September 2022 Share Issue/Capital Change	2022-10-05	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS Report Publication Announcement	2022-09-20	English
NOTIFICATION LETTER AND REQUEST FORM TO REGISTERED SHAREHOLDERS Report Publication Announcement	2022-09-20	English
2022 Interim Report Interim / Quarterly Report	2022-09-20	English
(I) GRANT OF OPTIONS UNDER THE 2021 SHARE OPTION SCHEME; (II) GRANT OF AWARDS TO EMPLOYEES UNDER THE 2021 SHARE AWARD SCHEME; AND (III) NON-EXEMPT CONNECTED TRANSACTION - PROPOSED CONNECTED Regulatory Filings	2022-09-09	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 August 2022 Major Shareholding Notification	2022-09-02	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022 Interim / Quarterly Report	2022-08-26	English
NOTICE OF BOARD MEETING Regulatory Filings	2022-08-16	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 July 2022 Share Issue/Capital Change	2022-08-04	English
Next Day Disclosure Return Share Issue/Capital Change	2022-07-18	English
Next Day Disclosure Return Share Issue/Capital Change	2022-07-15	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 June 2022 Regulatory Filings	2022-07-05	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 24, 2022 Declaration of Voting Results & Voting Rights Announcements	2022-06-24	English
INSIDE INFORMATION NEW DRUG APPLICATION OF OUR CORE PRODUCT OT-401 APPROVED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION Regulatory Filings	2022-06-21	English
CHANGE OF JOINT COMPANY SECRETARY, AUTHORIZED REPRESENTATIVE AND PROCESS AGENT AND WAIVER FROM STRICT COMPLIANCE WITH RULES 3.28 AND 8.17 OF THE LISTING RULES Board/Management Information	2022-06-15	English
VOLUNTARY ANNOUNCEMENT CDE APPROVAL RECEIVED FOR A PHASE III CLINICAL TRIAL OF OT-703 IN CHINA Regulatory Filings	2022-06-09	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 May 2022 Share Issue/Capital Change	2022-06-06	English
DISCLOSEABLE TRANSACTION RELATING TO THE PROMOTION AGREEMENT WITH VIATRIS Capital/Financing Update	2022-06-01	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 April 2022 Share Issue/Capital Change	2022-05-05	English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS Report Publication Announcement	2022-04-26	English
NOTIFICATION LETTER AND REQUEST FORM TO REGISTERED SHAREHOLDERS Report Publication Announcement	2022-04-26	English
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 24, 2022 Proxy Solicitation & Information Statement	2022-04-26	English
NOTICE OF ANNUAL GENERAL MEETING AGM Information	2022-04-26	English
PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES; PROPOSED RE-ELECTION OF RETIRING DIRECTORS; PROPOSED RE-APPOINTMENT OF AUDITOR; AND NOTICE OF ANNUAL GENERAL AGM Information	2022-04-26	English
2021 Environmental, Social and Governance Report Regulatory Filings	2022-04-26	English
2021 Annual Report Regulatory Filings	2022-04-26	English
List of Directors and their Role and Function Board/Management Information	2022-04-08	English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE IN COMPOSITION OF BOARD COMMITTEES Board/Management Information	2022-04-08	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2022 Share Issue/Capital Change	2022-04-06	English
List of Directors and their Role and Function Board/Management Information	2022-03-31	English
PASSING AWAY OF AN INDEPENDENT NON-EXECUTIVE DIRECTOR Board/Management Information	2022-03-31	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021 Annual Report	2022-03-25	English
DATE OF BOARD MEETING Regulatory Filings	2022-03-15	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 28 February 2022 Regulatory Filings	2022-03-03	English
VOLUNTARY ANNOUNCEMENT PRIMARY CLINICAL ENDPOINT ACHIEVED IN THE PHASE III CLINICAL TRIAL OF OT-1001 Regulatory Filings	2022-03-02	English
VOLUNTARY ANNOUNCEMENT COOPERATION WITH VIATRIS ON DISTRIBUTION AND PROMOTION OF OPHTHALMIC DRUGS Regulatory Filings	2022-03-01	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2022 Regulatory Filings	2022-02-08	English
Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 December 2021 Share Issue/Capital Change	2022-01-06	English
VOLUNTARY ANNOUNCEMENT FIRST PATIENT ENROLLED IN THE CLINICAL TRIAL OF SELF-DEVELOPED CLASS I NEW DRUG OT-202 IN CHINA Regulatory Filings	2022-01-04	English